![]() |
|
|
1 Biochemistry Section, Laboratory of Pharmacology, Baltimore Cancer Research Center, National Institutes of Health, National Cancer Institute, Baltimore, Maryland
A major metabolite of daunorubicin from human urine and enzymatic reactions was isolated and characterized. Comparative data from thin-layer chromatography, infrared spectroscopy, mass spectroscopy and chemical derivatization of daunorubicin, adriamycin and the metabolite indicated the metabolite to be the 13-hydroxydaunorubicin, daunorubicinol. The hydrolytic product of daunorubicinol, daunorubicinol aglycone, was a second metabolite.
Accepted on February 16, 1971
This article has been cited by other articles:
![]() |
G. Decorti, I. Peloso, D. Favarin, F. B. Klugmann, L. Candussio, E. Crivellato, F. Mallardi, and L. Baldini Handling of Doxorubicin by the LLC-PK1 Kidney Epithelial Cell Line J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 525 - 530. [Abstract] [Full Text] |
||||